ArticleFood chemistry: X2026
Origin-specific metabolomic profiling and network pharmacology propose potential multi-target antioxidant mechanisms of black sesame seeds.
Article in Food chemistry: X, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Black Sesame Seeds (BSS) are consumed as an edible herbal food with medicinal food homology and possess potent antioxidant properties; however, their metabolic compositions and corresponding antioxidant efficacies substantially vary across different geographical origins. This study investigates the underlying multi-component and multi-target antioxidant mechanisms of BSS from various geographical origins. An integrated computational and experimental approach combining UHPLC-Q-Exactive Orbitrap MS/MS-based metabolomics, network pharmacology, and molecular docking was employed. Metabolomic profiling identified a diverse array of active phytochemicals enriched in BSS, including lipophilic lignans (e.g., (+)-eudesmin), vitamin E derivatives (e.g., γ-tocotrienol), and hydrophilic flavonoids (e.g., quercetin). Subsequent network and structural biology analyses revealed that these diverse compounds exert complementary multi-target effects to mitigate oxidative stress by targeting core hub proteins, particularly AKT1 and TP53. Specifically, molecular docking demonstrated that lipophilic components exhibit strong binding affinities to the hydrophobic cavities of AKT1, whereas hydrophilic polyphenols establish robust hydrogen-bonding networks with TP53. Pathway enrichment analyses further suggested that BSS exerts its profound cytoprotective effects primarily by modulating the PI3K-Akt and apoptosis signaling cascades, thereby restoring intracellular redox homeostasis. In conclusion, this study systematically predicts the complex structural and pharmacological basis of BSS against oxidative damage, laying a solid theoretical hypothesis for the future development of BSS-derived natural antioxidants and functional therapeutics.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.